Cost effectiveness and affordability of trastuzumab in sub-Saharan Africa for early stage HER2-positive breast cancer

Noga Gershon, Yakir Berchenko, Peter S. Hall, Daniel A. Goldstein

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalCost Effectiveness and Resource Allocation
Volume17
Issue number1
DOIs
Publication statusPublished - 28 Feb 2019

Cite this